How Oral Dissolvable Films Are Transforming Pet Health Supplements
The global pet supplements market is projected to reach USD 4.6 billion by 2033, driven by pet humanization and growing health awareness among owners. Yet most pet supplements today are delivered through powders, tablets, or chewables that suffer from two persistent problems: low bioavailability and difficult administration. A new technology — oral dissolvable films — is emerging to address these gaps, and one of the early movers in this space is Novohope, a manufacturer that specializes in pet oral dissolving membrane health products.
Traditional Pet Supplements: What Holds Them Back
Conventional oral supplements for pets often deliver less than 40% of their active ingredients to the bloodstream. The pet digestive system — with a short intestine (< 1.2 m) and highly acidic stomach (pH 1–3) — degrades many nutrients before they can be absorbed. Owners also face daily struggles: hiding pills in food, forcing liquids, or dealing with food refusal. These compliance issues reduce the real-world effectiveness of even the best-formulated products.
The opportunity lies in a delivery format that bypasses the gut, dissolves quickly, and eliminates fighting. This is exactly what oral dissolvable films (ODFs) and orally disintegrating tablets (ODTs) offer.
Novohope’s Approach: A Film‑Based Supplement Line
Wuxi Novohope Biotechnology Co., Ltd. (established 2025) is a manufacturer dedicated to pet nutrition solutions. The company operates a 20,000 m² facility, employs an R&D team of 12 engineers, and has an annual production capacity of 200,000,000 boxes. Its export ratio is 95%, with markets in Europe, America, Britain, the Middle East, Japan, and South Korea.
Novohope’s product line consists of seven series: COAT+ (coat & skin), EYES+ (eye care & tear‑stain management), CALM+ (calming & stress relief), BONE+ (joint & bone health), HEART+ (cardiovascular), PROBIO (digestive care), and Fit+ (weight management). Each is delivered as an orally disintegrating film or tablet.
How the Oral Dissolving Film Works
The core technology originates from human medicine: a thin, postage‑stamp‑sized film that dissolves within 10 seconds upon contact with pet saliva. Instead of traveling through the stomach and intestines, the active ingredients are absorbed directly through the oral mucosa and enter the bloodstream. Novohope claims an absorption rate of up to 95%, compared with approximately 35% for traditional products.
Each product is made with an oral fast‑dissolving matrix combined with specific functional nutrients. For example, the EYES+ film (2.1 g per strip) contains Taurine, NAC, Lutein & Zeaxanthin; the PROBIO film (2.5 g per strip) delivers Bacillus coagulans (GBI‑30, 6086) at 1×10⁹ CFU per film. Dosage is precisely controlled per strip, ensuring consistency.
Real‑World Use Scenarios
Because the film requires no feeding tool and dissolves quickly, it fits naturally into daily routines:
- Tear‑stain reduction – EYES+ is formulated to manage unsightly stains around eyes, using antioxidants that support vision health.
- Calming during stress – CALM+ (α‑casozepine, L‑theanine) helps pets relax during travel, fireworks, or separation.
- Joint and bone support – BONE+ contains glucosamine HCl, hydrolyzed collagen, and UC‑II to improve mobility.
- Digestive maintenance – PROBIO provides probiotics (Bacillus coagulans) and postbiotics for gut health.
- Coat shine and skin health – COAT+ uses N‑acetylglucosamine, sodium hyaluronate, DHA & biotin.
The product is stored at room temperature and can be carried anywhere. The pet simply licks the film, and within seconds it dissolves — stress‑free for both animal and owner.
Market Context and Growth Drivers
According to Grand View Research, the global pet supplements market was valued at approximately USD 2.8 billion in 2025, with projections reaching USD 4.6 billion by 2033. North America currently holds 48.1% of global revenue. The Asia‑Pacific region is the fastest‑growing market, driven by rising pet humanization in China and India.
Oral dissolvable film technology for pets is still emerging. Industry reports indicate that most ODF products achieve disintegration times below 25 seconds; Novohope’s 10‑second specification is well within the leading performance tier. The combination of high absorption, precise dosage, and zero‑stress feeding positions this technology for strong adoption among premium brands and retailers.
How Films Compare with Traditional Formats
Compared with powders, tablets, and soft chews, ODFs offer clear advantages:
- Administration – No hiding or forcing; the pet accepts the film on its own.
- Bioavailability – Mucosal absorption bypasses the gut, dramatically improving ingredient utilization.
- Dosage accuracy – Each film is a pre‑measured unit, eliminating guesswork.
One honest limitation: the technology is relatively new to the pet market, so longer‑term palatability and stability data across all species and breeds are still accumulating. However, initial compliance and absorption metrics are compelling.
Future Outlook
As pet owners increasingly seek human‑grade, science‑backed nutrition, the demand for innovative delivery formats will grow. Novohope’s focus on ODF/ODT technology, combined with its in‑house R&D (12 engineers) and international certifications (FDA food registration, GS1 barcodes, SDS, COA), positions it as a competent partner for brands looking to enter or expand in the functional pet supplement space. The company’s first international debut at Interzoo in Nuremberg (May 2026) and the opening of a new R&D center in Shenzhen (June 2026) underline its commitment to global growth.
Frequently Asked Questions
- How fast does a Novohope oral film dissolve?
- It dissolves within 10 seconds upon contact with pet saliva.
- What absorption rate is claimed for these films?
- Up to 95%, compared with about 35% for traditional oral supplements.
- What product series are available under Novohope?
- Seven series: COAT+, EYES+, CALM+, BONE+, HEART+, PROBIO, and Fit+.
- Does Novohope offer contract manufacturing or OEM/ODM services?
- Yes, the company provides contract manufacturing, R&D, and brand agency services for the pet health industry.
- What certifications have the products obtained?
- Products have completed FDA food registration, obtained GS1 international product codes, and passed SDS and COA professional tests.
- What are the main export markets?
- Europe, America, Britain, the Middle East, Japan, and South Korea, with 95% of products exported.
Wuxi Novohope Biotechnology Co., Ltd.
Brand: Novohope
Website: https://novohope.pet
Contact: Frank
Email: NovoHope.pet@outlook.com
Tel: +86 1342809561 | WhatsApp: +86 1626 232 2952
Download Company Brochure (PDF)